(Q41717722)

7 October 2017

1 reference

title

California-La Crosse encephalitis (English)

1 reference

7 October 2017

0 references

McJunkin JE

1

1 reference

7 October 2017

Khan RR

series ordinal

2

1 reference

7 October 2017

Tsai TF

series ordinal

3

1 reference

7 October 2017

publication date

1 March 1998

1 reference

Infectious Disease Clinics of North America

7 October 2017

published in

1 reference

7 October 2017

volume

12

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

83-93

1 reference

Bunyavirus-vector interactions

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Mechanism of La Crosse virus inhibition by ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Detection of California serogroup viruses using universal primers and reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

California arbovirus encephalitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Serodiagnosis of La Crosse virus infections in humans by detection of immunoglobulin M class antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Acute disseminated encephalomyelitis presenting as a neurodegenerative disease in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Genetic determinants of the virulence and infectivity of La Crosse virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

The electroencephalogram and clinical sequelae of California arbovirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Requirement for the G1 protein of California encephalitis virus in infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Ribavirin therapy for Hantaan virus infection in suckling mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Infarction of basal ganglia associated with California encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Role of La Crosse virus glycoproteins in attachment of virus to host cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Psychological sequelae in children following California arbovirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Vertical Transmission of La Crosse Virus (California Encephalitis Group): Transovarial and Filial Infection Rates in Aedes Triseriatus (Diptera: Culicidae)1

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Studies on California encephalitis in Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Role of the middle-sized bunyavirus RNA segment in mouse virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

In vitro and in vivo Phlebovirus inhibition by ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

Transovarial transmission of LaCrosse virus in Aedes triseriatus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

1 reference

7 January 2021

Symptomatic La Crosse virus infections of the central nervous system: a study of risk factors in an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970410-4

7 January 2021

10.1016/S0891-5520(05)70410-4

Identifiers

DOI

1 reference

7 October 2017

1 reference